Immunome, Inc. (IMNM:NASDAQ) closed at $18.06 on October 27, 2026, up 0.95% on the day. The stock trades 39.9% below its 52-week high of $30.06 and 23.4% above its 52-week low of $14.64. Over the past year, it gained 7.8%. Immunome, Inc. is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, IMNM closed higher on 129 days (51%). Its best day was December 15, 2025 (+15.69%) and its worst was December 17, 2025 (-15.76%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
Immunome Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody-based drugs. The company's proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease. It is developing treatments for treating cancer and other infectious diseases.
Find more stocks like IMNM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.